| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/21/2004 | EP1381388A1 Production of peptides in plants as n-terminal viral coat protein fusions |
| 01/21/2004 | EP1381387A2 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 01/21/2004 | EP1381378A1 Compositions and methods for cancer prevention and treatment derived from inula britannica |
| 01/21/2004 | EP1381272A2 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors |
| 01/21/2004 | EP1242129B1 Biological joint construct |
| 01/21/2004 | EP1165573B1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes |
| 01/21/2004 | EP1010007B1 Collagen-peptide assay method |
| 01/21/2004 | EP0728213B1 Transgenic fructan accumulating crops and methods for their production |
| 01/21/2004 | EP0516664B1 Transgenic animals, cells and cell lines therefrom, and their use |
| 01/21/2004 | CN1469930A Cytomegalovirus intron a fragments |
| 01/21/2004 | CN1469928A Cytochrome P450 monooxygenases consisting of thermophilic bacteria |
| 01/21/2004 | CN1469926A Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2004 | CN1469923A Method of extensive culture of antigen-specific cytotoxic T cells |
| 01/21/2004 | CN1469739A Method for modulating bladder function |
| 01/21/2004 | CN1469705A Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680369 Nucleotide sequences coding protein for use in treatment cytoskeletal defects |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680293 Prevention of membrane formation; obtain cell tissue, incubate with inhibitory collagen, monitor membrane formation |
| 01/20/2004 | US6680199 Adding ionomycin to oocyte and preventing phosphorylation of the cellular proteins; adding serine-threonine kinase inhibitor such as 6-dimethylaminopurine |
| 01/20/2004 | US6680198 Engraftable human neural stem cells |
| 01/20/2004 | US6680197 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and t cells that are specific for cells expressing such polypeptides. |
| 01/20/2004 | US6680171 Drug screening, genetic engineering |
| 01/20/2004 | US6680170 Polynucleotides encoding STE20-related protein kinases and methods of use |
| 01/20/2004 | US6680052 Methods of inhibiting tumor growth using adenosine receptor activated cells |
| 01/20/2004 | US6678998 Floral packaging material having great masters prints thereon |
| 01/20/2004 | CA2258501C Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 01/20/2004 | CA2149705C Process for producing plant belonging to the section leuce |
| 01/20/2004 | CA2148599C Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
| 01/20/2004 | CA2101534C Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 01/20/2004 | CA2078235C Idiotypic vaccination against b cell lymphoma |
| 01/15/2004 | WO2004005871A1 A method of studying living cells |
| 01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/15/2004 | WO2004005516A1 Use of ahas mutant genes as selection marker in potato transformation |
| 01/15/2004 | WO2004005496A1 Novel undifferentiated stem cells contained in cord blood, bone marrow, peripheral blood or the like |
| 01/15/2004 | WO2004005494A1 Medium for culturing autologous human progenitor stem cells and applications thereof |
| 01/15/2004 | WO2004005493A1 Animal protein free media for cultivation of cells |
| 01/15/2004 | WO2004005491A1 Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
| 01/15/2004 | WO2004005488A2 Replacing liver cells with bone marrow-derived cells for treating disease and expressing therapeutic genes |
| 01/15/2004 | WO2004005480A2 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | WO2004005474A2 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | WO2004005473A2 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | WO2004005470A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 01/15/2004 | WO2004005460A2 Antisense modulation of hmg-coa reductase expression |
| 01/15/2004 | WO2004005453A1 Culture dish and bioreactor system |
| 01/15/2004 | WO2004005348A1 SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2 |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2004004763A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 01/15/2004 | WO2004004687A2 Liposomal vaccine |
| 01/15/2004 | WO2004004663A2 Compositions and methods for ligament growth and repair |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2004004447A2 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/15/2004 | WO2003090513A3 Bi-specific antigen-binding compositions and related methods |
| 01/15/2004 | WO2003087337A3 Vascularized human skin equivalent |
| 01/15/2004 | WO2003073827A3 Methods of modulating dendritic cells using adjuvants |
| 01/15/2004 | WO2003072728A3 Cellular trans-differentiation |
| 01/15/2004 | WO2003065004A3 Enzyme activation protease assay |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | WO2003060130A3 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/15/2004 | WO2003060072A3 Recombinant polypeptides |
| 01/15/2004 | WO2003059260A3 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 01/15/2004 | WO2003055992A3 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 01/15/2004 | WO2003050271A3 In vitro production of dendritic cells from cd14+ monocytes |
| 01/15/2004 | WO2003048731A3 Antibody categorization based on binding characteristics |
| 01/15/2004 | WO2003048313A3 Cell culture media |
| 01/15/2004 | WO2003045995A3 Cell culture process |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2003014383A3 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002072607A3 Soluble heterodimeric cytokine receptor |
| 01/15/2004 | WO2002060935A8 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010813 Comprises nucleotide sequences capable of heart specific transcription for treating cardiomyopathies and cardiovascular disorders; anticardiopathic agents; drug screening |
| 01/15/2004 | US20040010812 Comprises nucleotide sequences coding receptor for hyaluronic acid mediated motility (RHAMM) for diagnosing, preventing, prognosing and treating tumor disorders; gene expression inhibition; antisense therapy |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009947 Compounds and methods for enhancing delivery of free polynucleotide |
| 01/15/2004 | US20040009936 Vaccine and drug delivery by topical application of vectors and vector extracts |
| 01/15/2004 | US20040009604 Plasmid which codes envelop fusogenic membrane protein for treating cell proliferative disorders; antitumor agents; immunotherapy; gene therapy |
| 01/15/2004 | US20040009598 Enhancing bone cell production and treating osteoarthritis, tissue injuries and congenital disorders |
| 01/15/2004 | US20040009596 Extract from an Indian green mussel (perna viridis) for differentiation and maturation of dendric cells |
| 01/15/2004 | US20040009595 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 01/15/2004 | US20040009594 Propagating cytotoxic t lymphocytes from hemopoietic stem cells and using them for treating cancer; immunotherapy |
| 01/15/2004 | US20040009593 Differentiated cell population which generate glial cells for treating central nervous system traumas and disorders |
| 01/15/2004 | US20040009592 Genetically-modified neural progenitors and uses thereof |
| 01/15/2004 | US20040009591 Keratinocytes expressing exogenous angiogenic growth factors |
| 01/15/2004 | US20040009590 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
| 01/15/2004 | US20040009589 Endothelial cells derived from human embryonic stem cells |
| 01/15/2004 | US20040009588 Comprises targeted adenoviral expression vector coding antitumor agent; gene therapy; gene expression inhibition |
| 01/15/2004 | US20040009569 Kinase crystal structures and materials and methods for kinase activation |
| 01/15/2004 | US20040009568 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 01/15/2004 | US20040009566 Cultured myocardial cell sheet which retains contracting and relaxing functions for diagnosing and treating cardiovascular, digestive and circulatory organ disorders; animal models |
| 01/15/2004 | US20040009559 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 01/15/2004 | US20040009558 Ligand binding pocket peptide fragment of the estrogen-related receptor 3 (ERR3) and uses thereof |
| 01/15/2004 | US20040009557 Comprises nucleotide sequences coding non-gum arabic fusion protein for use in food processing and cosmetics |
| 01/15/2004 | US20040009555 Comprises nucleotide sequences coding gum arabic for use in food processing and cosmetics |
| 01/15/2004 | US20040009554 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |